Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 128
A systematic review of the research progress of non-coding RNA in neuroinflammation and immune regulation in cerebral infarction/ischemia-reperfusion injury
Kailin Yang, Liuting Zeng, Anqi Ge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
A dual-signal amplification strategy based on rolling circle amplification and APE1-assisted amplification for highly sensitive and specific miRNA analysis for early diagnosis of alzheimer's disease
Juan Xie, Jing Chen, Ya Zhang, et al.
Talanta (2024) Vol. 272, pp. 125747-125747
Closed Access | Times Cited: 6
Development and preliminary validation of five miRNAs for lung adenocarcinoma prognostic model associated with immune infiltration
Yang Huan-zhang, Jiang Hua, Yanxia Han, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advancements in gene therapies targeting mutant KRAS in cancers
Yuhang Wang, Thuỳ Anh Bùi, Xinpu Yang, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2+ and TNBC) Cells—A Proof of Principle Investigation
I-Peng Chen, Stefan Henning, Marc Bender, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3629-3629
Open Access
The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells
Elham Shokati, Elahe Safari
International Immunopharmacology (2023) Vol. 120, pp. 110267-110267
Closed Access | Times Cited: 11
Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma
Е. Н. Воропаева, Yuriy L. Orlov, A. B. Loginova, et al.
PeerJ (2025) Vol. 13, pp. e18661-e18661
Open Access
IFN-τ Maintains Immune Tolerance by Promoting M2 Macrophage Polarization via Modulation of Bta-miR-30b-5p in Early Uterine Pregnancy in Dairy Cows
Xinyu Feng, Yang Cheng, Ting Wang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 87-87
Open Access
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Management of intrahepatic cholangiocarcinoma: a review for clinicians
Matteo Colangelo, Marcello Di Martino, Michela Anna Polidoro, et al.
Gastroenterology report (2025) Vol. 13
Open Access
ncRNA-Mediated Pyroptosis in Cerebral Ischemia-Reperfusion Injury: Pathophysiology, Mechanisms, and Therapeutic Perspectives
Ruiyi Xu, Peng Quan, Wen Chen, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 141-141
Open Access
Micro-RNA-140-3p Acts as a Tumor Suppressor Gene in Acute Promyelocytic Leukemia by Targeting Hepatocyte Growth Factor
Ruiqi Lei, Xin Liu, Yiting Wu, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Non-coding RNAs in breast cancer: Implications for programmed cell death
Yan Luo, Weiqiang Tang, Shasha Xiang, et al.
Cancer Letters (2022) Vol. 550, pp. 215929-215929
Closed Access | Times Cited: 18
Emerging Progress of RNA-Based Antitumor Therapeutics
Jiayan Fu, Haiyang Dong, Jian Wu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3159-3183
Open Access | Times Cited: 9
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration
Rui Chen, Elaina Coleborn, Chintan Bhavsar, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100725-100725
Open Access | Times Cited: 9
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment
Zhengjia Zhang, Xinyi Luo, Xiaoxia Xue, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 743-758
Open Access | Times Cited: 3
Circ_0036490 and DKK1 competitively bind miR-29a to promote lipopolysaccharides-induced human gingival fibroblasts injury
Yeke Wu, Bin Li, Disi Deng, et al.
Autoimmunity (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death
Eun Hye Kim, Jiwoong Choi, Hochung Jang, et al.
Theranostics (2024) Vol. 14, Iss. 10, pp. 3777-3792
Open Access | Times Cited: 3
miRNAs and arsenic-induced carcinogenesis
Alexandra N. Nail, Ana P. Ferragut Cardoso, Lakyn K. Montero, et al.
Advances in pharmacology (2023), pp. 203-240
Open Access | Times Cited: 8
Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer
Shufeng Ji, Hao Yu, Dan Zhou, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
An APE1 gated signal amplified biosensor driven by catalytic hairpin assembly for the specific imaging of microRNA in situ
Mengxin Zhang, Yingyu Zhang, Qionglin Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129902-129902
Closed Access | Times Cited: 2
Pivotal role of MiRNA's in malignant transformation of Oral Submucous Fibrosis
J H Shazia Fathima, Selvaraj Jayaraman, Asma Abdullah Nurul, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100299-100299
Open Access | Times Cited: 2
Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway
Yulun Wu, Yuhan Xiao, Yongxing Ding, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113261-113261
Closed Access | Times Cited: 2
miRNA interplay: Mechanisms and therapeutic interventions in cancer
Zehua Wang, Hongwei Wang, Shuhan Zhou, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top